Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors

Franco Chimenti, Daniela Secci, Adriana Bolasco, Paola Chimenti, Arianna Granese, Simone Carradori, Elias Maccioni, M. Cristina Cardia, Matilde Yanez, Francisco Orallo, Stefano Alcaro, Francesco Ortuso, Roberto Cirilli, Rosella Ferretti, Simona Distinto, Johannes Kirchmair, Thierry Langer

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Pages (from-to)5063-5070
Number of pages8
JournalBioorganic & Medicinal Chemistry
Volume18
Issue number14
DOIs
Publication statusPublished - 15 Jul 2010
Externally publishedYes

Funding

This work was supported by MURST (Italy), Ministerio de Sanidad y Consumo (Spain; FISS PI061537) and Xunta de Galicia (Spain; INCITE07PXI203039ES, INCITE08E1R203054ES, and 08CSA019 203PR).

Austrian Fields of Science 2012

  • 301207 Pharmaceutical chemistry

Keywords

  • Hydrazothiazole derivatives
  • 3D-QSAR
  • Human monoamine oxidase B inhibitors
  • PHARMACOPHORE-BASED ALIGNMENT
  • PARKINSONS-DISEASE
  • THIAZOLE DERIVATIVES
  • MAO-B
  • VALIDATION
  • HYDRAZINES
  • BINDING
  • FIELD
  • GENE

Fingerprint

Dive into the research topics of 'Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors'. Together they form a unique fingerprint.

Cite this